Thanks for your research again Mr Mutton!
This brochure is outstanding. The scalp, back and arm photos, while graphic, highlight just what BTM can do. The neck photos are even more graphic... and without words provide compelling evidence for new surgeons to use BTM. It is no surprise how PNV managed to poach a serious US sales team and the strategy of direct sales is clearly the right one here.
A serious congratulations to Paul Brennan, the PNV employees and board... but also to Adelaide surgeons Prof John Greenwood and Marcus Wagstaff for having the determination and skill to take this through trials and save both lives and long term suffering.
This brochure makes me proud to be a shareholder and increases my confidence further in just how well PNV will do long term... bring on US sales data.
Happy summer holidays to all and may 2017 be the defining year taking a small Australian speculative biotech into a solid reliable and bluechip!
Gav
Thanks for your research again Mr Mutton! This brochure is...
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.41 |
Change
-0.010(0.41%) |
Mkt cap ! $1.663B | |||
| Open | High | Low | Value | Volume |
| $2.43 | $2.43 | $2.38 | $4.263M | 1.765M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 30432 | $2.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.41 | 8889 | 2 |
View Market Depth
| Last trade - 16.10pm 20/06/2024 (20 minute delay) ? |
| PNV (ASX) Chart |